Will Medicare cover Zepbound and other weight loss drugs in 2026?

Question

Matt Maresch · Accepted Answer

Yes, but it is important to understand that this is not blanket coverage for everyone.

Starting July 1, 2026, Medicare is expected to provide access to certain GLP-1 weight loss drugs through what is called the Medicare GLP-1 Bridge program. This would apply to eligible people who have Medicare Part D coverage.

The drugs currently listed under this program include Foundayo, Wegovy, and Zepbound. For Zepbound, Medicare specifically lists the Zepbound KwikPen, not the single-dose vials or pens.

This is also a temporary program. It is scheduled to run from July 1, 2026 through December 31, 2027. One important detail is that this program operates outside the normal Part D payment system, which means Part D plans do not have to opt in for eligible beneficiaries to access the program.

The expected cost is a $50 copay for a one-month supply. However, that $50 does not count toward the Part D deductible or the annual out-of-pocket limit, and it cannot be reduced by Extra Help or LIS.

The biggest thing to understand is that eligibility is not simply based on wanting to lose weight. A provider would need to submit a prior authorization, and the patient would need to meet certain clinical requirements.

Those requirements may include BMI levels along with specific health conditions. For example, someone may qualify based on a BMI of 35 or higher, a BMI of 30 or higher with certain conditions such as heart failure, uncontrolled hypertension, or chronic kidney disease, or a BMI of 27 or higher with conditions such as prediabetes, a prior heart attack, prior stroke, or peripheral artery disease.

It is also important to separate weight loss coverage from coverage for another medical diagnosis. If a GLP-1 medication is prescribed for a Medicare-coverable diagnosis, such as Type 2 diabetes, obstructive sleep apnea, or MASH, that would generally be reviewed through the person’s regular Part D plan, not the GLP-1 Bridge program.

So the short answer is yes, but not for everyone.

Ali Hall · Answer

Here is an email I recently sent my clients: Starting July 1, 2026, Medicare is launching the GLP-1 Bridge Program, which for the first time ever allows eligible Medicare members to access FDA-approved weight-loss medications at just $50/month. The covered drugs are Wegovy®, Zepbound® (KwikPen®), and Foundayo®.

To qualify, you generally need to:

•        Be enrolled in a Medicare Part D or Medicare Advantage plan with drug coverage

•        Need the medication for weight loss (not for diabetes or another condition)

•        Meet clinical criteria set by your doctor

•        Have your doctor submit a prior authorization through the Bridge Program

This program runs through December 31, 2027 and operates separately from your regular Part D plan.

If you think you might qualify or just want to talk through whether this applies to your situation please don’t hesitate to reach out. I’m happy to help!

Rich Baker · Answer

Starting July 1 2026 Medicare will be running an 18 month program which will cover GLP1s for weight loss. The covered drugs are Wegovy, Zepbound, and Foundayo. The copay will be $50 for eligible beneficiaries and this is being handled outside of your part D coverage, so none of the costs go toward your $2100 TrOOP. Talk to your PCP or go to Medicare.gov to get more information. Note that requests cannot be submitted before July 1st.

Answered by Rich Baker on June 24, 2026

Broker Licensed in CO, AR, AZ & 9 other states

Answered by Rich Baker Medicare Insurance Agent

Vernon Jones · Answer

Yes, starting July 1, 2026, Zepbound (KwikPen) and Wegovy will be covered for weight loss under the temporary Medicare GLP-1 Bridge Program for a fixed $50 monthly copay

Mary Brown · Answer

Yes, for many people, beginning July 1, 2026, Medicare will provide access to Zepbound, Wegovy, and certain other GLP-1 weight-loss medications through the new Medicare GLP-1 Bridge program. Eligibility requirements apply, including having Medicare Part D and meeting the program's medical criteria.

Answered by Mary Brown on June 29, 2026

Broker Licensed in NJ, DE, FL & NC, OH, PA & TX

Answered by Mary Brown Medicare Insurance Agent

James Hale · Answer

Medicare generally does NOT cover Zepbound, Wegovy, or similar weight loss medications when they’re prescribed just for weight loss.

Medicare may cover Zepbound or similar medications if your doctor prescribes them for an FDA-approved medical condition, such as:

>Type 2 diabetes
>Obstructive sleep apnea (in some cases)
>Reducing cardiovascular risk

NOTE: In these situations, coverage depends on your specific Part D plan and whether the drug is on the formulary.

Bottom Line:
Pure weight loss = Not covered
Weight loss + another qualifying condition = Possibly covered

Kristina Guerry · Answer

Medicare is introducing a trial program, GLP-1 Bridge, from 07/01/2026- to 12/31/2027. 
For the treatment of obesity and weight loss, you may be eligible to have Foundayo (tablet), Wegovy (injection or tablet) and Zepbound Kwikpen (injection) with a $50 copay.
If the pharmacy bills your drug plan, it will be rejected.

Andrew Zurbuch, MBA · Answer

Medicare GLP1's.

Beginning July 1, 2026, Medicare will make certain Glp-1 medications available to eligible Medicare Part D policyholders for the treatment of obesity and weight loss under the Bridge Program.  This is a temporary in that will run through December 31, 2027.
Medicare will manage this program. This is separate from the Medicare Beneficiary’s Medicare Part D coverage.

Source: Anthem BC/BS Medicare.  

Plans are insured or covered by a Medicare Advantage (HMO, PPO and PFFS) organization with a Medicare contract and/or a Medicare-approved Part D sponsor. Enrollment in the plan depends on the plan’s contract renewal with Medicare. We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare to get information on all of your options.

Will Medicare cover Zepbound and other weight loss drugs in 2026?

Agents: Share Your Expertise

Seniors: Ask a Question of Your Own

Related Questions

Agent Locator

Medicare Agents Hub
A non-government resource website

Will Medicare cover Zepbound and other weight loss drugs in 2026?

Agents: Share Your Expertise

Seniors: Ask a Question of Your Own

Related Questions

Agent Locator

Medicare Agents HubA non-government resource website

Medicare Agents Hub
A non-government resource website